ISO 18362:2016

Manufacture of cell-based health care products — Control of microbial risks during processing

Standard Details

ISO 18362:2016 specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled 'sterile' and to CBHPs not labelled 'sterile'.

ISO 18362:2016 is not applicable to:

- procurement and transport of cell-based starting material used in processing of a CBHP,

- cell banking,

- control of genetic material,

- control of non-microbial product contamination,

- in vitro diagnostics (IVDs), or

- natural medicines.

EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids.

ISO 18362:2016 does not define biosafety containment requirements.

ISO 18362:2016 does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.

General Information

Status : Published

Standard Type: Main

Document No: ISO 18362:2016

Document Year: 2016

Pages: 32

Edition: 1

Section Volume:
ISO/TC 198. Sterilization of health care products

ICS:
11.080.01 Sterilization and disinfection in general

Preview Document

Life Cycle

Currently Viewing

Published

ISO 18362:2016

ISO 18362:2016

Standard Details

General Information

Life Cycle

Add Standards To Trackedge

Enquiry Form